T2	SecondaryOutcome 952 1022	Improvement of cardinal respiratory symptoms such as cough and dyspnea
T3	TimeFrame 1023 1039	within two weeks
R1	MeasuredAt Arg1:T2 Arg2:T3	
T4	SecondaryOutcome 1276 1285	lassitude
T1	PrimaryOutcome 75 84	mortality
T7	SecondaryOutcome 1420 1425	fever
T8	SecondaryOutcome 1427 1435	headache
T9	SecondaryOutcome 1441 1466	gastrointestinal symptoms
T10	SecondaryOutcome 1535 1566	improvement in the level of LDH
T11	SecondaryOutcome 1651 1654	CRP
T12	SecondaryOutcome 1608 1611	NLR
T13	TimeFrame 1682 1698	within two weeks
R2	MeasuredAt Arg1:T10 Arg2:T13	
R3	MeasuredAt Arg1:T12 Arg2:T13	
R4	MeasuredAt Arg1:T11 Arg2:T13	
T15	SecondaryOutcome 1784 1814	length of stay in the hospital
T16	TimeFrame 1815 1848	[from randomization to discharge]
R5	MeasuredAt Arg1:T15 Arg2:T16	
T14	TimeFrame 68 74	28-day
R6	MeasuredAt Arg1:T1 Arg2:T14	
T17	PrimaryOutcome 418 431	ICU admission
T5	PrimaryOutcome 741 778	intubation and mechanical ventilation
